Innovation in Phase I Clinical Development
Practical approaches to phase I trial development in order to enable faster go / no-go decisions, reduce cost and speed time to market
20 - 22 September, 2010, Marriott Hotel, Munich, Germany
Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010. With the focus on cost control more important than ever, phase I clinical trials are becoming an increasingly crucial cog in the drug development process as the bid to save time and money has spurred innovation in trial design and processes at all levels. Investment in phase I has the potential to reduce overall costs by enabling faster go/no go decisions, which is why 40% of trials are now in phase I and the pressure is on to deliver results at an early stage. The Innovation in Phase I Clinical Development conference offers the opportunity to discover new methodologies, cost saving strategies and clarify changes to the regulatory landscape in a bid to reach proof of concept and make go/no go decisions as soon as possible.